Mates Sharon 4
4 · Benitec Biopharma Inc. · Filed Nov 7, 2025
Insider Transaction Report
Form 4
Mates Sharon
Director
Transactions
- Award
Options (right to buy)
2025-11-05+28,517→ 28,517 totalExercise: $15.78Exp: 2035-11-05→ Common Stock (28,517 underlying)
Footnotes (1)
- [F1]The Options will vest in full on the earlier of immediately prior to the Issuer's 2026 annual meeting of stockholders and November 5, 2026.